By Peter A. McCullough, MD, MPH
Many of our readers have wondered why about ~25% of adult Americans take statins. The weakest case for statins would be treatment of adults with no history of atherosclerotic cardiovascular disease. This report from Chou et al for the US Preventative Services Task Force, historically a very conservative guidelines body, gives the evidence from 19 randomized trials involving 71,344 participants.
The results clearly demonstrated the following significant reductions after treatment for ~2 years:
14% reduction in all cause mortality
18% reduction in cardiovascular mortality
29% reduction in stroke
36% reduction in myocardial infarction
